Study guide
16.3 Neuroanaesthesia: Craniotomy, Sitting Position, and Traumatic Brain Injury
EDAIC Part I European Diploma in Anaesthesiology and Intensive Care
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: The EDAIC Part I Examination
1.1 EDAIC Part I Exam Format, Scoring and Multiple True/False Strategy
2 Chapter 2: Anatomy for Anaesthesia and Intensive Care
2.1 Functional Anatomy of the Upper Airway, Larynx, and Tracheobronchial Tree 2.2 Neuraxial Anatomy: Spine, Spinal Cord, Meninges, and Spaces 2.3 Vascular Anatomy for Central and Peripheral Cannulation 2.4 Peripheral Nerve Plexuses and Autonomic Nervous System Pathways 2.5 Thoracic Anatomy: Chest Wall, Intercostal Spaces, Pleura, Mediastinum and Heart
3 Chapter 3: Respiratory and Cardiovascular Physiology
3.1 Respiratory Mechanics, Lung Volumes, and Work of Breathing 3.2 Ventilation-Perfusion Relationships, Shunt, and Gas Exchange 3.3 Control of Breathing, Hypoxia, Altitude and Hyperbaric Physiology 3.4 Cardiac Cycle, Electrophysiology, and Ventricular Function 3.5 Vascular Resistance, Microcirculation, and Systemic Hemodynamics
4 Chapter 4: Neurophysiology, Renal, Hepatic and Acid-Base Physiology
4.1 Cerebral Blood Flow, Intracranial Pressure, and CSF Dynamics 4.2 Renal Physiology, Glomerular Filtration, and Tubular Transport 4.3 Hepatic Blood Flow, Metabolism, and Clearance 4.4 Acid-Base Regulation, Buffering Systems, and Stewart Approach
5 Chapter 5: Endocrine and Haematological Physiology
5.1 Endocrine Physiology and the Neuroendocrine Stress Response 5.2 Haemostasis Physiology, Coagulation Testing and Inherited Bleeding Disorders
6 Chapter 6: Special Patient Physiology: Maternal, Paediatric and Geriatric
6.1 Maternal Physiological Adaptations to Pregnancy and Uteroplacental Flow 6.2 Neonatal and Paediatric Physiological Differences 6.3 Physiological Changes of Ageing and Thermoregulation
7 Chapter 7: General Pharmacological Principles and Inhalational Anaesthetics
7.1 Pharmacokinetic Principles, Compartmental Models, and Clearance 7.2 Pharmacodynamic Mechanisms, Receptor Theory, and Drug Interactions 7.3 Physical Properties, Uptake, and Distribution of Volatile Anaesthetics 7.4 Minimum Alveolar Concentration (MAC), Organ Effects, and Toxicity
8 Chapter 8: Intravenous Agents, Neuromuscular Blockade and Analgesics
8.1 Intravenous Induction Agents: Propofol, Etomidate, Ketamine, and Barbiturates 8.2 Neuromuscular Blocking Agents: Depolarizing and Non-Depolarizing Drugs 8.3 Neuromuscular Monitoring and Reversal: Anticholinesterases and Sugammadex 8.4 Opioid Pharmacology, Receptors, and Non-Opioid Analgesic Agents
9 Chapter 9: Cardiovascular Drugs, Autonomic Pharmacology and Local Anaesthetics
9.1 Inotropes, Vasopressors, and Inodilators in Perioperative Care 9.2 Antiarrhythmic, Antihypertensive, and Beta-Adrenergic Antagonist Drugs 9.3 Local Anaesthetic Pharmacology, Toxicity (LAST), and Lipid Emulsion Therapy
10 Chapter 10: Haematological and Internal Medicine Pharmacology
10.1 Anticoagulant, Antiplatelet and Haemostatic Drugs and Their Reversal 10.2 Internal Medicine Drugs: Endocrine, Respiratory, Psychiatric and Antiepileptic Agents and Their Anaesthetic Interactions
11 Chapter 11: Physics, Clinical Measurement and Medical Equipment
11.1 Physical Gas Laws, Fluid Dynamics, and Resistance Principles 11.2 Anaesthetic Machines, Gas Supply Pipelines, Cylinders, and Safety Mechanisms 11.3 Breathing Systems, Vaporizer Mechanics, and Scavenging Systems 11.4 Invasive and Non-Invasive Hemodynamic and Respiratory Monitoring
12 Chapter 12: Electrical Safety, Temperature, Humidity and Gas Analysis
12.1 Electricity, Electrical Safety, Diathermy, Defibrillation, Implanted Devices and Fire 12.2 Temperature Measurement, Humidity, Gas Analysis and SI Units
13 Chapter 13: Biostatistics, Clinical Trials and Evidence Appraisal
13.1 Descriptive Statistics, Distributions, and Parametric vs Non-Parametric Tests 13.2 Hypothesis Testing, Power, Type I/II Errors, and Confidence Intervals 13.3 Clinical Study Designs, Bias, and Diagnostic Test Performance (Sensitivity, Specificity, ROC)
14 Chapter 14: General Anaesthesia, Preoperative Evaluation and Airway Management
14.1 Preoperative Risk Assessment, Cardiovascular Risk Indices, and Fasting Guidelines 14.2 The Difficult Airway: Assessment, Algorithms, and Rescue Oxygenation 14.3 Intraoperative Fluid Therapy, Goal-Directed Hemodynamics, and Blood Conservation 14.4 Post-Anaesthesia Care Unit (PACU) Management, Emergence, and Postoperative Nausea/Vomiting
15 Chapter 15: Coexisting Disease and Preoperative Investigations
15.1 Interpreting Investigations: ECG, Chest Radiograph, Lung Function and Blood Tests 15.2 Coexisting Disease I: Asthma, COPD, Obstructive Sleep Apnoea, Obesity, Liver and Renal Disease 15.3 Endocrine Disease and Emergencies: Diabetes, DKA and HHS, Thyroid, Adrenal, Phaeochromocytoma and Carcinoid 15.4 Coexisting Disease II: Neuromuscular and Neurological Disease
16 Chapter 16: Subspecialty Anaesthesia: Cardiothoracic, Vascular and Neuroanaesthesia
16.1 Anaesthesia for Cardiac Surgery and Cardiopulmonary Bypass Management 16.2 Thoracic Anaesthesia, One-Lung Ventilation, and Major Vascular Surgery 16.3 Neuroanaesthesia: Craniotomy, Sitting Position, and Traumatic Brain Injury
17 Chapter 17: Obstetric, Paediatric and Ambulatory Anaesthesia
17.1 Obstetric Analgesia and Anaesthesia: Labour, Caesarean Delivery, and High-Risk Conditions 17.2 Paediatric Anaesthesia: Induction, Airway Management, and Emergencies 17.3 Ambulatory Day-Surgery Selection, Premedication, and Elderly Patient Anaesthesia
18 Chapter 18: Anaesthetic Complications and Specialty Settings
18.1 Anaesthetic Complications: Accidental Awareness, Aspiration, Positioning Injuries, Visual Loss and Dental Damage 18.2 Anaesthesia for ENT and Laser Airway Surgery, Ophthalmic Surgery, and Laparoscopic and Robotic Surgery
19 Chapter 19: Regional Anaesthesia and Acute/Chronic Pain Management
19.1 Neuraxial Techniques: Spinal, Epidural, and Caudal Anaesthesia 19.2 Upper and Lower Limb Peripheral Nerve and Fascial Plane Blocks 19.3 Multimodal Acute Postoperative Pain Management and ERAS Pathways 19.4 Chronic and Neuropathic Pain Syndromes and Interventional Management 19.5 Palliative Symptom Control, Psychological Aspects of Pain and Multidisciplinary Pain Management
20 Chapter 20: Intensive Care Medicine: Ventilation, Shock and Organ Support
20.1 Acute Respiratory Distress Syndrome (ARDS) and Mechanical Ventilation Strategies 20.2 Sepsis-3 Definitions, Septic Shock, and Hemodynamic Resuscitation 20.3 Acute Kidney Injury, Indications for Dialysis, and Continuous Renal Replacement Therapy 20.4 ICU Sedation, Delirium, Weaning, and Brain Death Determination
21 Chapter 21: Intensive Care Medicine: Admission, Nutrition, Infection and Electrolytes
21.1 ICU Admission, Severity Scoring, Nutrition and Routine Prophylaxis 21.2 Antimicrobial Therapy, Stewardship and ICU-Acquired Infections 21.3 Electrolyte Disorders: Sodium, Potassium, Calcium, Magnesium and Phosphate
22 Chapter 22: Intensive Care and Emergency Medicine: Neurocritical Care, Poisoning and Cardiorespiratory Emergencies
22.1 Neurocritical Care: Subarachnoid Haemorrhage, Stroke, Status Epilepticus and Acute Neuromuscular Failure 22.2 Acute Poisoning: Toxidromes, Decontamination and Specific Antidotes 22.3 Acute Cardiorespiratory Emergencies: Pulmonary Embolism, Acute Severe Asthma and COPD, Non-Invasive Support and Acute Heart Failure
23 Chapter 23: Resuscitation, Perioperative Emergencies and Professional Ethics
23.1 Advanced Life Support (ALS) Guidelines and Perioperative Cardiac Arrest 23.2 Perioperative Crises: Malignant Hyperthermia and Severe Anaphylaxis 23.3 Major Trauma, Hemorrhagic Shock, and Massive Transfusion Protocols 23.4 Professional Ethics, Informed Consent, Patient Safety, and Helsinki Declaration
24 Chapter 24: Newborn, Paediatric and Obstetric Emergencies
24.1 Newborn Life Support and Paediatric Life Support 24.2 Obstetric Emergencies: Maternal Collapse, Amniotic Fluid Embolism, Uterine Inversion and Resuscitative Hysterotomy
25 Chapter 25: Burns, Environmental Emergencies and Patient Transport
25.1 Burns, Inhalation Injury, Drowning, Hypothermia, Heat Illness and Decompression Illness 25.2 Prehospital Care and Intra- and Inter-Hospital Transport of the Critically Ill
16.3 Neuroanaesthesia: Craniotomy, Sitting Position, and Traumatic Brain Injury
Key Takeaways Explain This Topic AI
Cerebral Perfusion Pressure is calculated as C P P = M A P − I C P CPP = MAP - ICP CPP = M A P − I CP (or CVP, whichever is higher); clinical neuroprotection mandates maintaining C P P ≥ 60 − 70 mmHg CPP \ge 60-70\text{ mmHg} CPP ≥ 60 − 70 mmHg while aggressively preventing secondary insults: hypoxia ( P a O 2 < 60 mmHg P_a\text{O}_2 < 60\text{ mmHg} P a O 2 < 60 mmHg ), hypotension ( S B P < 100 − 110 mmHg SBP < 100-110\text{ mmHg} SBP < 100 − 110 mmHg ), hyperthermia, and hyperglycemia.
The Monro-Kellie doctrine dictates that the total volume of brain parenchyma, blood, and CSF within the rigid skull is fixed; ICP is rapidly reduced using 30° head elevation, osmotherapy (mannitol 0.5-1.0 g/kg or 3% hypertonic saline targeting serum osmolarity < 320 mOsm/kg), and mild targeted hypocapnia ( P a CO 2 30 − 35 mmHg P_a\text{CO}_2 30-35\text{ mmHg} P a CO 2 30 − 35 mmHg ).
The sitting position provides optimal posterior fossa exposure and gravity drainage, but carries high risks of postural hypotension, mid-cervical quadriplegia, and Venous Air Embolism (VAE); transesophageal echocardiography is the most sensitive diagnostic monitor for VAE, followed by precordial Doppler ultrasound and sudden drops in E T CO 2 ET\text{CO}_2 ET CO 2 .
Brain Trauma Foundation guidelines for severe TBI require maintaining S B P ≥ 100 − 110 mmHg SBP \ge 100-110\text{ mmHg} SBP ≥ 100 − 110 mmHg , treating I C P > 22 mmHg ICP > 22\text{ mmHg} I CP > 22 mmHg , avoiding prophylactic hyperventilation ( P a CO 2 ≤ 25 mmHg P_a\text{CO}_2 \le 25\text{ mmHg} P a CO 2 ≤ 25 mmHg ) during the first 24 hours, strictly withholding corticosteroids (CRASH trial), and providing 7-day post-traumatic seizure prophylaxis.
Last updated: October 2026
16.3 Neuroanaesthesia: Craniotomy, Sitting Position, and Traumatic Brain Injury
Neuroanaesthesia centers on a primary mandate: providing an immotile, "slack" operative field while preserving cerebral perfusion and preventing secondary neurological injury. The adult cranium is a rigid, non-distensible vault, making intracranial dynamics exceptionally sensitive to physiological perturbations.
1. Principles of Neuroanaesthesia and Secondary Brain Injury
Intracranial compliance and cerebral blood flow regulation govern intraoperative cerebral stability.
Cerebral Perfusion Pressure and Autoregulation
Cerebral Perfusion Pressure (CPP) is the effective pressure gradient driving cerebral blood flow (CBF) across the cerebral capillary bed: C P P = M A P − I C P ( or M A P − C V P , whichever is higher ) CPP = MAP - ICP \quad (\text{or } MAP - CVP, \text{whichever is higher}) CPP = M A P − I CP ( or M A P − C V P , whichever is higher )
Normal Physiological Values: Normal ICP is 5 to 15 mmHg in supine adults. Intracranial hypertension is defined as sustained ICP > 20 to 22 mmHg \text{ICP} > 20\text{ to }22\text{ mmHg} ICP > 20 to 22 mmHg requiring active clinical intervention.
Target CPP: In both elective neurosurgery and traumatic brain injury, target CPP is maintained between 60 and 70 mmHg . CPP < 60 mmHg <60\text{ mmHg} < 60 mmHg induces focal or global cerebral ischemia, whereas excessive CPP ( > 70 – 80 mmHg >70\text{--}80\text{ mmHg} > 70 – 80 mmHg ) risks vasogenic edema, disruption of the blood-brain barrier (BBB), and acute lung injury.
Cerebral Autoregulation: In the intact brain, CBF remains constant (~ 50 mL/100g/min 50\text{ mL/100g/min} 50 mL/100g/min ) across a Mean Arterial Pressure (MAP) range of 50 to 150 mmHg (or CPP of 60 to 140 mmHg). Beyond these limits, CBF becomes pressure-passive. In acute traumatic brain injury or surrounding intracranial tumours, autoregulation is frequently impaired or completely abolished, rendering the brain exceptionally vulnerable to ischemic injury from even modest drops in blood pressure.
Avoidance of Secondary Brain Injury (The "H-Bombs" of Neuroanaesthesia)
Primary mechanical damage (contusion, laceration, hematoma) occurs at the time of impact. Secondary brain injury develops over subsequent hours to days via cellular, metabolic, and inflammatory cascades. Anaesthetic management is aimed at preventing systemic physiological triggers that exacerbate secondary injury:
Hypoxia ( P a O 2 < 60 mmHg P_a\text{O}_2 < 60\text{ mmHg} P a O 2 < 60 mmHg or S p O 2 < 90 % Sp\text{O}_2 < 90\% Sp O 2 < 90% ): Triggers immediate intracellular energy failure, ATP exhaustion, failure of N a + / K + Na^+/K^+ N a + / K + ATPase pumps, cytotoxic edema, and doubles perioperative mortality.
Hypotension ( S B P < 100 − 110 mmHg SBP < 100-110\text{ mmHg} SBP < 100 − 110 mmHg or M A P < 80 mmHg MAP < 80\text{ mmHg} M A P < 80 mmHg ): In the injured or non-compliant brain, drops in perfusion pressure directly compromise cerebral blood flow in ischemic penumbra regions.
Hyperthermia (Core Temp > 37.5 °C >37.5\text{°C} > 37.5 °C ): Every 1°C increase in core temperature elevates the Cerebral Metabolic Rate of Oxygen ( C M R O 2 CMRO_2 CMR O 2 ) by ~7% , accelerating neurotransmitter toxicity (glutamate excitotoxicity) and lipid peroxidation. Active normothermia (36.0°C-37.0°C) must be maintained.
Hyperglycemia (Blood Glucose > 10 mmol/L >10\text{ mmol/L} > 10 mmol/L / > 180 mg/dL >180\text{ mg/dL} > 180 mg/dL ): Accelerates anaerobic metabolism in ischemic neurons, precipitating intracellular lactic acidosis, reactive oxygen species formation, and disruption of the blood-brain barrier.
Extreme Hypo/Hypercapnia:
Hypercapnia ( P a CO 2 > 45 mmHg P_a\text{CO}_2 > 45\text{ mmHg} P a CO 2 > 45 mmHg ): Induces marked cerebral arteriolar vasodilation, expanding Cerebral Blood Volume (CBV) and causing acute spikes in ICP.
Severe Hypocapnia ( P a CO 2 < 28 − 30 mmHg P_a\text{CO}_2 < 28-30\text{ mmHg} P a CO 2 < 28 − 30 mmHg ): Triggers extreme cerebral arteriolar vasoconstriction, shifts the oxyhemoglobin dissociation curve to the left (Bohr effect, impairing oxygen unloading), and induces severe focal cerebral ischemia.
2. The Monro-Kellie Doctrine and ICP Reduction Strategies
The Monro-Kellie Hypothesis dictates that the rigid adult cranial cavity has a fixed internal volume ( V total ≈ 1400 – 1700 mL V_{\text{total}} \approx 1400\text{--}1700\text{ mL} V total ≈ 1400 – 1700 mL ), partitioned into three mutually incompressible compartments: V total = V brain ( 80 % ) + V blood ( 10 % ) + V CSF ( 10 % ) = Constant V_{\text{total}} = V_{\text{brain}} (80\%) + V_{\text{blood}} (10\%) + V_{\text{CSF}} (10\%) = \text{Constant} V total = V brain ( 80% ) + V blood ( 10% ) + V CSF ( 10% ) = Constant An increase in the volume of any one compartment (or the introduction of a pathological mass, e.g. tumour, hematoma, abscess) must be compensated by an equal reduction in the volume of the other compartments. Initial compensation occurs via displacement of CSF into the spinal subarachnoid space and translocation of venous blood into the internal jugular veins. Once these compensatory spatial reserves are exhausted, the intracranial compliance curve steepens exponentially: tiny increases in volume produce massive, life-threatening spikes in ICP, culminating in fatal transtentorial or tonsillar herniation. ICP
- ^
- | / (Decompensated Phase)
- | /
- | / Exponential rise in ICP
- | /
- | (Compensated /
- | Phase) /
- | +------------------+
- | | Displacement of |
- | | CSF and venous |
- | | blood |
- | _______________+ |
- +--------------------------------------------------------> Intracranial Mass Volume
- Therapeutic Modalities to Modulate Intracranial Compartments
Compartment Interventions Physiological Mechanism & Targets
Venous Blood Volume ( V blood V_{\text{blood}} V blood ) Head elevation 30° ; Neutral head position; Avoid constrictive ties; Mild positive end-expiratory pressure. Enhances gravity drainage of internal jugular veins. Eliminates venous engorgement. Ensuring the head is not rotated, flexed, or compressed prevents obstruction of the internal jugular veins.
Arterial Blood Volume ( V blood V_{\text{blood}} V blood ) Targeted mild hypocapnia ( P a CO 2 30 − 35 mmHg P_a\text{CO}_2 30-35\text{ mmHg} P a CO 2 30 − 35 mmHg ); Avoid vasodilators; Deep anaesthesia / Propofol. CBF changes linearly by 1 to 2 mL/100g/min 1\text{ to }2\text{ mL/100g/min} 1 to 2 mL/100g/min per 1 mmHg 1\text{ mmHg} 1 mmHg change in P a CO 2 P_a\text{CO}_2 P a CO 2 between about 20 and 80 mmHg. Arteriolar vasoconstriction reduces cerebral blood volume, decompressing the brain.
Brain Parenchyma ( V brain V_{\text{brain}} V brain ) Mannitol 20% ( 0.5 − 1.0 g/kg 0.5-1.0\text{ g/kg} 0.5 − 1.0 g/kg ); Hypertonic Saline (HTS 3%) ( 2 − 3 mL/kg 2-3\text{ mL/kg} 2 − 3 mL/kg ). Generates an osmotic gradient across an intact Blood-Brain Barrier (BBB), drawing free water from the intracellular/interstitial space of healthy brain tissue into the intravascular space. Target serum osmolarity < 320 mOsm/kg <320\text{ mOsm/kg} < 320 mOsm/kg .
Cerebrospinal Fluid ( V CSF V_{\text{CSF}} V CSF ) External Ventricular Drain (EVD) ; Lumbar drain (if no non-communicating mass lesion). Direct external diversion and evacuation of CSF volume ( 1 mL 1\text{ mL} 1 mL CSF removed drops ICP substantially when compliance is exhausted).
Cellular Metabolism ( C M R O 2 CMRO_2 CMR O 2 ) Propofol infusion ; Thiopental / Barbiturates; Normothermia. Flow-metabolism coupling: decreasing neuronal metabolic electrical activity reduces C M R O 2 CMRO_2 CMR O 2 , which in turn triggers coupled reductions in CBF and CBV. Propofol titrates down to burst suppression on EEG.
Osmotherapy: Mannitol vs Hypertonic Saline
Mannitol 20% (0.5 to 1.0 g/kg IV over 15-20 minutes):
Biphasic Action: First, an immediate rheological effect : expands plasma volume, dilutes hematocrit, lowers blood viscosity, and improves microcirculatory capillary flow, reflexively triggering cerebral autoregulatory vasoconstriction that reduces CBV within minutes. Second, an osmotic effect (onset 15-30 min, duration 4-6 hours): the intact BBB (reflection coefficient σ = 0.9 \sigma = 0.9 σ = 0.9 ) prevents mannitol entry, establishing an osmotic gradient that dehydrates brain parenchyma. Excreted unchanged in urine via osmotic diuresis.
Hazards: Initial transient volume expansion can precipitate acute pulmonary edema in heart failure. Subsequent intense osmotic diuresis causes hypovolemia, hypotension, hypokalemia, and hypernatremia. If serum osmolarity exceeds 320 mOsm/kg , severe hyperosmolar acute tubular injury occurs.
Hypertonic Saline (HTS 3%, 7.5%, or 23.4%; typically 3% NaCl at 2 to 3 mL/kg or 150-250 mL bolus):
Mechanism: Highest reflection coefficient ( σ = 1.0 \sigma = 1.0 σ = 1.0 ) across the BBB, meaning the intact membrane is completely impermeable to sodium ions. Superior osmotic pull per milliliter compared to mannitol. Additionally expands intravascular volume, increases MAP, bolsters CPP, restores neuronal resting membrane potentials, and modulates neuroinflammation.
Key Advantage: Does not induce mandatory osmotic diuresis; ideal in polytrauma patients presenting with hypovolemia or hemodynamic instability. Target serum sodium maintained at ≤ 155 mmol/L \le 155\text{ mmol/L} ≤ 155 mmol/L ; target serum osmolarity < 320 mOsm/kg <320\text{ mOsm/kg} < 320 mOsm/kg .
3. Neuroanaesthesia for Craniotomy and Awake Brain Mapping
Anaesthesia for elective supratentorial craniotomy must facilitate smooth induction, total immobility, blunting of extreme sympathetic reflexes during skull-pin application (Mayfield head clamp), a relaxed brain, and rapid, cough-free emergence to permit immediate neurological examination.
Awake Craniotomy for Eloquent Cortex Mapping
Indicated for resecting intra-axial tumours (e.g. low-grade gliomas) or epileptogenic foci adjacent to eloquent cortex (Broca's speech area in inferior frontal gyrus, Wernicke's receptive language area in superior temporal gyrus, primary motor cortex in precentral gyrus, or sensory cortex in postcentral gyrus).
Anaesthetic Techniques:
Asleep-Awake-Asleep (AAA): Patient is placed under general anaesthesia with a supraglottic airway (LMA) or endotracheal tube during skull pinning, incision, and bone flap removal. Anaesthesia is discontinued, the airway device removed, and the patient awakened fully for direct cortical electrical stimulation and continuous language/motor testing. Following mapping and resection, the patient is re-anesthetized and the airway re-secured for closure.
Monitored Anaesthesia Care (MAC) / Conscious Sedation: Patient remains spontaneously breathing throughout the procedure. Target-Controlled Infusion (TCI) of Dexmedetomidine (loading 0.5-1.0 μ g/kg \mu\text{g/kg} μ g/kg , maintenance 0.2-0.7 μ g/kg/hr \mu\text{g/kg/hr} μ g/kg/hr ) combined with low-dose remifentanil is the modern technique of choice. Dexmedetomidine provides cooperative sedation, anxiolysis, and analgesia without respiratory depression or blunting intraoperative electrocorticography (ECoG).
The Scalp Block: Regional Innervation of the Cranium
A flawless bilateral scalp block is essential for awake craniotomy and highly advantageous for all craniotomies to ablate the hemodynamic surge of skull-pin fixation. The scalp is innervated by six distinct nerves bilaterally (12 total injections): [ REGIONAL INNERVATION OF THE SCALP ]
- Vertex
- |
- +-------------------------+-------------------------+
- | |
- ANTERIOR SCALP POSTERIOR SCALP
- (Trigeminal Nerve, CN V) (Cervical Spinal Nerves)
- | |
- CN V1 (Ophthalmic): - C2-C3 Ventral Rami:
- * Supraorbital Nerve * Lesser Occipital Nerve
- * Supratrochlear Nerve (retroauricular groove)
- CN V2 (Maxillary): - C2 Dorsal Ramus:
- * Zygomaticotemporal Nerve * Greater Occipital Nerve
- CN V3 (Mandibular): (medial to occipital artery)
* Auriculotemporal Nerve - C3 Dorsal Ramus:
(anterior to tragus) * Third Occipital Nerve
Nerve Origin Anatomical Landmark / Injection Technique
1. Supraorbital Nerve Ophthalmic division (CN V 1 V_1 V 1 ), via frontal nerve. Emerges through the supraorbital notch/foramen in the superior orbital rim (in line with pupil). Injected directly at the notch.
2. Supratrochlear Nerve Ophthalmic division (CN V 1 V_1 V 1 ), via frontal nerve. Emerges above the inner canthus of the eye; injected at the superomedial orbital angle above the trochlea.
3. Zygomaticotemporal Nerve Maxillary division (CN V 2 V_2 V 2 ). Emerges at the lateral orbital border; injected from the lateral orbital rim to the temporal crest.
4. Auriculotemporal Nerve Mandibular division (CN V 3 V_3 V 3 ). Injected immediately anterior to the tragus of the external ear, superior to the zygomatic arch (aspirate to avoid superficial temporal artery).
5. Lesser Occipital Nerve Cervical plexus (ventral rami of C2-C3). Injected along the posterior border of the sternocleidomastoid muscle and behind the ear along the mastoid process.
6. Greater Occipital Nerve Dorsal ramus of C2. Injected midway between the external occipital protuberance (inion) and the mastoid process, immediately medial to the pulsating occipital artery.
4. The Sitting Position for Posterior Fossa Surgery and Venous Air Embolism
Neurosurgical procedures in the sitting (park-bench or upright) position are utilized for lesions of the posterior cranial fossa, cerebellopontine angle (acoustic neuroma), pineal region, and upper cervical spine.
Clinical Trade-Offs of the Sitting Position
Advantages: Unrivaled surgical access and visibility; gravity-assisted drainage of blood and CSF away from the microscopic field; reduced intraoperative blood loss; lower intracranial venous pressure; preservation of lower cranial nerves.
Disadvantages and Physiological Hazards:
Profound Postural Hypotension: Severe venous pooling in lower limbs and splanchnic circulation drops venous return, stroke volume, and MAP. Transducers must be zeroed at the external auditory meatus (level of the Circle of Willis) ; hydrostatic difference means arterial pressure at the brain is 15 to 20 mmHg lower than pressure measured at heart level.
Mid-Cervical Quadriplegia & Cord Ischemia: Severe hyperflexion of the neck can occlude the anterior spinal artery or compress the upper cervical spinal cord against the vertebral column. Ensure at least two fingerbreadths between the chin and sternum.
Macroglossia and Upper Airway Obstruction: Extreme neck flexion obstructs lingual venous and lymphatic drainage, causing massive tongue swelling postoperatively.
Venous Air Embolism (VAE): The preeminent life-threatening hazard.
Venous Air Embolism (VAE) Pathophysiology
When the operative site is elevated above the level of the right atrium, the hydrostatic pressure within dural venous sinuses drops below atmospheric pressure ( P venous < P atmosphere P_{\text{venous}} < P_{\text{atmosphere}} P venous < P atmosphere ). The dural venous sinuses are tethered to the rigid cranial periosteum and cannot collapse . When incised or torn by the surgeon, air is continuously sucked into the venous circulation.
Consequences: Entrained air travels via the internal jugular veins to the right atrium, right ventricle, and pulmonary arterial circulation. Microvascular bubbles trigger acute pulmonary vasoconstriction, bronchoconstriction, pulmonary hypertension, and acute right ventricular failure. Large air volumes form an "air lock" in the right ventricular outflow tract (RVOT), causing instantaneous circulatory arrest.
Paradoxical Air Embolism (PAE): In patients with a Patent Foramen Ovale (PFO) (present in 25-30% of the general population), elevated right atrial pressure from pulmonary embolization forces air right-to-left across the septum into the systemic circulation, causing immediate catastrophic stroke or coronary air embolism. Preoperative echocardiography with an agitated saline contrast (bubble) study is recommended to screen for a PFO before elective sitting-position surgery .
Diagnostic Sensitivity Ranking for VAE [ SENSITIVITY SPECTRUM FOR DETECTING VENOUS AIR EMBOLISM ]
- HIGHEST SENSITIVITY (Detects 0.02 mL/kg air) = Transesophageal Echocardiography (TEE)
- |
- v
- Precordial Doppler Ultrasound (Detects 0.05 mL/kg; roaring/mill-wheel sound)
- |
- v
- End-Tidal Carbon Dioxide (Sharp drop in ETCO2 due to alveolar dead space)
- |
- v
- End-Tidal Nitrogen (ETN2 rise; reflects expired nitrogen gas)
- |
- v
- Pulmonary Artery Catheter (Acute spike in PAP)
- |
- v
- LOWEST SENSITIVITY (Late/Catastrophic Signs) = Mill-wheel murmur on stethoscope,
- hypotension, arrhythmias, cardiac arrest
Transesophageal Echocardiography (TEE): The undisputed gold standard and most sensitive diagnostic monitor. Detects microbubbles as small as 0.02 mL/kg in the right atrium or entering the left atrium via a PFO.
Precordial Doppler Ultrasound: Non-invasive, highly sensitive (detects 0.05 mL/kg ). Positioned over the right sternal border between the 3rd and 6th intercostal spaces. Detects turbulent air bubbles as a characteristic harsh, churning sound (the "roaring" or "mill-wheel" Doppler signal) long before hemodynamic changes occur.
Capnography ( E T CO 2 ET\text{CO}_2 ET CO 2 ): Rapid, sharp decline in end-tidal C O 2 CO_2 C O 2 with a concomitant rise in P a CO 2 P_a\text{CO}_2 P a CO 2 . Pulmonary microvascular air embolization occludes capillary beds, creating a massive increase in alveolar dead space (ventilated but unperfused alveoli).
End-Tidal Nitrogen ( E T N 2 ET\text{N}_2 ET N 2 ): Detects exhaled nitrogen gas as entrained atmospheric air is cleared across the alveolar membrane (specific, but requires absence of background nitrous oxide).
Precordial Stethoscope: Detects the classical "mill-wheel murmur" (a loud, churning mechanical sound over the precordium). This is a late sign of massive air-lock and hemodynamic collapse.
Emergency Management Protocol for VAE
If air entrainment is detected, the team must immediately execute the following multi-step algorithm:
Notify the surgical team immediately: Surgeon must instantly flood the operative field with sterile normal saline and pack bone edges with bone wax and dural margins with wet cottonoids to stop air suction.
Discontinue Nitrous Oxide ( N 2 O N_2O N 2 O ) and administer 100% O 2 O_2 O 2 : N 2 O N_2O N 2 O diffuses rapidly into closed air bubbles, expanding their volume up to three-fold and drastically accelerating vascular occlusion.
Compress bilateral internal jugular veins: Compressing the jugular veins transiently raises cranial venous pressure above atmospheric, converting air entrainment into visible retrograde venous bleeding, which allows the surgeon to identify and coagulate the open vessel.
Aspirate air from the right atrium: Using a pre-placed multi-orifice right atrial catheter (e.g. Bunegin-Albin catheter , with its tip positioned 1 to 2 cm below the cavoatrial junction in the high right atrium), apply continuous syringe suction to aspirate foam and air bubbles.
Position adjustment: If feasible, lower the operative table to level the head, or position the patient in the left lateral decubitus position with Trendelenburg (Durant maneuver) to trap air at the right ventricular apex, relieving RVOT obstruction.
Hemodynamic support: Administer rapid IV crystalloid boluses, inotropes (epinephrine), and vasopressors to sustain perfusion; initiate external chest compressions if cardiac arrest supervenes (compressions help crush large air locks into smaller microbubbles that pass through the pulmonary capillary bed).
5. Traumatic Brain Injury (TBI) and Brain Trauma Foundation Guidelines
Traumatic brain injury is a major cause of death and disability globally. Contemporary management focuses on secondary insult prevention, adherence to Brain Trauma Foundation (BTF 4th Edition) protocols, and timely surgical evacuation of mass lesions (extradural hematoma, acute subdural hematoma, depressed skull fracture). [ BRAIN TRAUMA FOUNDATION (BTF) PROTOCOLS ]
- |
- +------------------+------------------+------------------+------------------+
- | | | | |
- [ Blood Pressure ] [ ICP Threshold ] [ Target CPP ] [ Ventilation ] [ Contraindicated ]
- SBP >= 100 mmHg - Treat if - Target: - Normocapnia: - NO Steroids
- (age 50-69) ICP > 22 mmHg 60-70 mmHg PaCO2 35-40 (CRASH Trial)
- SBP >= 110 mmHg - Place EVD or - Avoid CPP - NO Prophylactic - NO Prophylactic
- (age 15-49, >70) intraparenchymal < 60 or > 70 Hyperventilation Hypothermia
- Evidence-Based BTF Clinical Management Targets
Blood Pressure Targets:
Maintain S B P ≥ 100 mmHg SBP \ge 100\text{ mmHg} SBP ≥ 100 mmHg for patients aged 50 to 69 years.
Maintain S B P ≥ 110 mmHg SBP \ge 110\text{ mmHg} SBP ≥ 110 mmHg for patients aged 15 to 49 years or > 70 >70 > 70 years.
Rationale: A single episode of intraoperative or pre-hospital hypotension ( S B P < 90 mmHg SBP < 90\text{ mmHg} SBP < 90 mmHg ) is associated with a doubling of mortality.
Intracranial Pressure (ICP) Monitoring Indications:
The BTF 4th edition recommends ICP monitoring in severe TBI to reduce in-hospital and 2-week mortality (Level IIB). Its indications are carried over from the 3rd edition (not supported by evidence meeting current standards): all salvageable patients with severe TBI ( GCS 3 to 8 after resuscitation) and an abnormal admission CT scan (showing hematomas, contusions, swelling, herniation, or compressed basal cisterns).
Also indicated in severe TBI with a normal CT scan if two or more of the following risk factors are present: age > 40 >40 > 40 years, unilateral or bilateral motor posturing (decerebrate/decorticate), or systolic blood pressure < 90 mmHg <90\text{ mmHg} < 90 mmHg .
ICP Intervention Threshold: Initiate medical and surgical ICP-lowering therapies when sustained ICP > 22 mmHg \text{ICP} > 22\text{ mmHg} ICP > 22 mmHg . The 4th edition (Level IIB) recommends treatment above 22 mmHg because higher values are associated with increased mortality.
Target Cerebral Perfusion Pressure (CPP):
Maintain target CPP strictly between 60 and 70 mmHg .
Avoid deliberate aggressive driving of CPP > 70 mmHg >70\text{ mmHg} > 70 mmHg using vasopressors and high fluids, which significantly increases the incidence of Acute Respiratory Distress Syndrome (ARDS) via capillary leak without improving neurological outcome.
Ventilatory Management:
Maintain strict normocapnia ( P a CO 2 35 to 40 mmHg P_a\text{CO}_2 35\text{ to }40\text{ mmHg} P a CO 2 35 to 40 mmHg ).
Prophylactic hyperventilation ( P a CO 2 ≤ 25 mmHg P_a\text{CO}_2 \le 25\text{ mmHg} P a CO 2 ≤ 25 mmHg ) is strictly avoided during the first 24 hours post-injury. During the initial 24 hours, global cerebral blood flow is naturally halved; severe hypocapnia-induced vasoconstriction precipitates catastrophic secondary cerebral ischemia. Hyperventilation is reserved strictly as a brief, emergency bridge ( P a CO 2 30 − 35 mmHg P_a\text{CO}_2 30-35\text{ mmHg} P a CO 2 30 − 35 mmHg ) for acute neurological deterioration or impending herniation while preparing for definitive decompression.
Corticosteroids: Strictly contraindicated . The landmark CRASH trial (Corticosteroid Randomization After Significant Head Injury; > 10,000 >10{,}000 > 10 , 000 patients) demonstrated that high-dose methylprednisolone administration in acute TBI significantly increased 14-day and 6-month mortality and is a Class I harm recommendation.
Seizure Prophylaxis: Post-traumatic seizure prophylaxis with Levetiracetam (Keppra) or Phenytoin is recommended for the first 7 days following severe TBI to reduce the incidence of early post-traumatic seizures. Anticonvulsants do not prevent late post-traumatic epilepsy and should be discontinued after day 7 unless clinical seizures occur.
Sedation and Neuromuscular Blockade: Propofol or midazolam infusions titrated to control ICP, coupled with opioid analgesia (fentanyl/remifentanil). Routine continuous neuromuscular blockade is not recommended unless refractory shivering, coughing, or ICP spikes occur despite deep sedation.